Together Overcoming Diabetes - Great Plains for American Indian/Alaska Native Adults

This study, called "Together Overcoming Diabetes - Great Plains," is testing a program designed to help American Indian and Alaska Native families manage diabetes. The program, called TOD Great Plains, offers home visits and activities tailored to address diabetes management and family health. Some participants will receive this program, while others will be on a waitlist and receive standard care. The main goal is to see if the TOD Great Plains program can improve blood sugar control, measured by glycated hemoglobin (HbA1c) levels, over 12 months. You may be able to join if you are an American Indian or Alaska Native adult, 18 years or older, live near Rapid City, have Type 2 Diabetes confirmed by a doctor, and care for a young person (10-25 years old) in your home. The current recruitment status is unclear.

Study design: This study is an interventional study planning to enroll 140 participants. It compares the TOD Great Plains program to a waitlist standard of care.
What's involved: You would have your glycated hemoglobin (HbA1c) measured at the start, and again at 3, 6, and 12 months.
Compensation: Not stated in the trial record.
Follow-up: Participants will be followed for 12 months after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Together Overcoming Diabetes - Great Plains

Recruiting

NAAges 10+InterventionalPrevention

Johns Hopkins Bloomberg School of Public Health

~140 participants

Updated 2026-01-23 on ClinicalTrials.gov

What's tested:TOD Great PlainsWaitlist Standard of Care

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Glycated hemoglobin (HbA1c)

Measured over Baseline, 3 months, 6 months, and 12 months

Conditions

Diabetes

Where it's being run

1 sites across 1 states

South Dakota1

Study leadership

Donald Warne, MD, MPH · PRINCIPAL_INVESTIGATOR · Johns Hopkins University

Who to contact

Courtney Claussen, PhD

[email protected]

605-200-0043

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

18 years and older

Self-identifies as American Indian or Alaska Native

Rapid City-based participants who reside within 1 hour transportation range of the Oyate Health Center

Verification from a health provider to confirm Type 2 Diabetes diagnosis by laboratory test.

Caregiver to a 10- to 25-year-old in their home at the time of screening.

Willing to complete all implementation and follow-up assessments.

Willing to be randomized for the intervention.

Between 10 years and 25 years old

Self-identifies as American Indian or Alaska Native.

Willing to serve as 'support person' for the adult participant.

Willing to complete all implementation and follow-up assessments.

Willing to be randomized for the intervention.

Exclusion

Inability to participate in full intervention or evaluation (e.g., planned move, residential treatment, etc.)

Willing to serve as 'support person' for the adult participant.

Has a circumstance that might impact successful participation based on provider judgment considering instances where diabetes control can become more difficult with advanced disease or special conditions including: pregnant, nursing, or planning to become pregnant, end-stage renal disease on dialysis, diabetes due to secondary causes such as Cushing's or Cystic Fibrosis, or any condition that may inhibit participation

Cognitively or visually impaired

Youth in foster care (due to potential mobility of foster youth).

What this trial measures

Glycated hemoglobin (HbA1c)Baseline, 3 months, 6 months, and 12 months
Glycated hemoglobin as measured by a point-of-care A1c test

Trialytics